Circulation: Cardiovascular Interventions

FEBRUARY 27, 2024

Circulation: Cardiovascular Interventions, Ahead of Print. BACKGROUND:The American College of Cardiology Reduce the Risk: PCI Bleed Campaign was a hospital-based quality improvement campaign designed to reduce post-percutaneous coronary intervention (PCI) bleeding events.

Myocardial Infarction 45

Myocardial Infarction Hospital Cardiovascular Interventions Outcomes 45

Circulation: Cardiovascular Interventions

MARCH 26, 2025

Circulation: Cardiovascular Interventions, Ahead of Print. The primary outcome was a composite of death from any cause, stroke/transient ischemic attack, and procedure-related or valve-related hospitalization at 30 days and at 1 year. versus 4.3%; hazard ratio, 2.93 [95% CI, 1.455.94]). andP=0.001, respectively).

Aortic valve 40

Aortic valve Aortic Stenosis TAVR 40

Circulation: Cardiovascular Interventions

DECEMBER 4, 2024

Circulation: Cardiovascular Interventions, Ahead of Print.

Cardiovascular Interventions 40

Cardiovascular Interventions Technology Circulation Hospital 40

Circulation: Cardiovascular Interventions

JANUARY 18, 2024

Circulation: Cardiovascular Interventions, Ahead of Print. with functional MR) who underwent an isolated, first-time intervention. with functional MR) who underwent an isolated, first-time intervention. METHODS:We retrospectively analyzed 968 individuals (median age, 79 [interquartile range, 70–86] years; 60.0%

Bicuspid/Mitral 40

Bicuspid/Mitral Outcomes Heart Failure Echocardiogram 40

Circulation: Cardiovascular Interventions

DECEMBER 27, 2024

Circulation: Cardiovascular Interventions, Ahead of Print. BACKGROUND:Varying rates of nonsustained ventricular tachycardia (NSVT) have been reported early after transcatheter pulmonary valve replacement (TPVR) with the Harmony valve, but data regarding rhythm outcomes beyond hospital discharge are limited.

Pulmonary 40

Pulmonary Arrhythmia Cardiovascular Interventions Tachycardia 40

Circulation: Cardiovascular Interventions

FEBRUARY 13, 2024

Circulation: Cardiovascular Interventions, Ahead of Print. BACKGROUND:Improved radiation safety practices are needed across hospitals performing percutaneous coronary intervention (PCI).

Cardiovascular Interventions 40

Cardiovascular Interventions Education Hospital Circulation 40

Circulation: Cardiovascular Interventions

FEBRUARY 20, 2024

Circulation: Cardiovascular Interventions, Ahead of Print. BACKGROUND:Patients with ST-segment–elevation myocardial infarction but no coronary microvascular injury are at low risk of early cardiovascular complications (ECC).

Myocardial Infarction 40

Myocardial Infarction STEMI Cardiogenic Shock Cardiac Arrest 40

Circulation: Cardiovascular Interventions

FEBRUARY 27, 2024

Circulation: Cardiovascular Interventions, Ahead of Print. INTRODUCTION:Percutaneous coronary intervention for complex coronary disease is associated with a high risk of cardiogenic shock. Cardiogenic shock and acute ST-segment–elevation myocardial infarction are exclusions.

Cardiogenic Shock 40

Cardiogenic Shock Myocardial Infarction Coronary Artery Disease Quality of Life 40

Circulation: Cardiovascular Interventions

OCTOBER 17, 2023

Circulation: Cardiovascular Interventions, Ahead of Print. Poverall=NS) were nonsignificant, and the incidence of overall in-hospital complications was comparable among groups. BACKGROUND:Data concerning the outcomes of transcatheter aortic valve replacement in type 0 bicuspid aortic stenosis (AS) are scarce.

Aortic valve 40

Aortic valve Bicuspid/Mitral Aortic Tricuspid 40

Circulation: Cardiovascular Interventions

JANUARY 31, 2024

Circulation: Cardiovascular Interventions, Ahead of Print. BACKGROUND:In patients with ST-segment–elevation myocardial infarction complicated by cardiogenic shock, primary percutaneous coronary intervention (pPCI) is the preferred revascularization option. pharmacoinvasive and 46.2% pharmacoinvasive and 46.2%

Cardiogenic Shock 40

Cardiogenic Shock Myocardial Infarction Cardiac Arrest Cardiovascular Interventions 40

Circulation: Cardiovascular Interventions

JANUARY 20, 2025

Circulation: Cardiovascular Interventions, Volume 18, Issue 1 , Page e014499, January 1, 2025. days;P=0.01) and hospital length of stay (5.0 METHODS:This retrospective cohort study analyzed data from 2 academic centers involving patients with intermediate-risk PE from January 2020 to January 2024. days;P=0.046).

Embolism 40

Embolism Pulmonary Outcomes Cardiac Arrest 40

Circulation: Cardiovascular Interventions

FEBRUARY 27, 2024

Circulation: Cardiovascular Interventions, Ahead of Print. 1.22]), in-hospital mortality (odds ratio, 0.64 [95% CI, 0.17–2.19]), Background:The role of advanced therapies (systemic thrombolysis, catheter-based treatment, and surgical thrombectomy) for the management of right heart thrombus is poorly defined.

Outcomes 40

Outcomes Thrombolysis Embolism Pulmonary 40

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4142612-A4142612, November 12, 2024. Background:The CHIP score, developed from the BCIS (British Cardiovascular Intervention Society) database, predicts adverse in-hospital MACCE (major adverse cardiovascular and cerebrovascular events).

Myocardial Infarction 40

Myocardial Infarction Cardiovascular Interventions Stroke Strokes 40

DAIC

OCTOBER 16, 2024

16, 2024 — Sahajanand Medical Technologies (SMT) recently announced the publication of the COMPARE 60/80 HBR trial results in Circulation: Cardiovascular Interventions , a journal of The American Heart Association. tim.hodson Wed, 10/16/2024 - 09:00 Oct. Led by Dr. Pieter C. Principal Investigator, Dr. Pieter C.

Stents 52

Stents Stent Thrombosis Coronary Artery Disease 52

DAIC

MARCH 15, 2024

Tang is currently serving as a professor in the Department of Cardiovascular Surgery at the Icahn School of Medicine at Mount Sinai , the surgical director of the Structural Heart Program at the Mount Sinai Health System, and the director of Structural Heart Education at the Mount Sinai Fuster Heart Hospital in New York.

TAVR 52

TAVR Academic Education Cardiovascular Surgery 52

Dr. Smith's ECG Blog

DECEMBER 7, 2023

Circulation: Cardiovascular Interventions , 7(5), 645–655. On hospital day 3, the patient had recurrence of symptoms and the following EKG was obtained. Dr. Frick's Interpretation of ECG #5 : CP did not recur during the remainder of the hospital stay. Starovoytov, A., Robinson, S., Vuurmans, T., Humphries, K., &

SCAD 124

SCAD Ischemia Coronary Artery Disease Cardiomyopathy 124

DAIC

DECEMBER 26, 2023

Professor of Medicine at the Yale School of Medicine and Director of the Y ale New Haven Hospital Center for Outcomes Research and Evaluation.

Innovation 52

Innovation Research Cardiovascular Imaging Electrophysiology 52

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Institutional Coronary Artery Bypass Case Volumes and Outcomes European Journal of Heart Failure October 2023 Makoto Mori Robotic Mitral Valve Repair for Degenerative Mitral Regurgitation The Annals of Thoracic Surgery August 2023 Carlos Diaz-Castrillion Volume-Failure to Rescue Relationship in Acute Type A Aortic Dissections: An Analysis of The Society (..)

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Institutional Coronary Artery Bypass Case Volumes and Outcomes European Journal of Heart Failure October 2023 Makoto Mori 1 Robotic Mitral Valve Repair for Degenerative Mitral Regurgitation The Annals of Thoracic Surgery August 2023 Carlos Diaz-Castrillion 2 Volume-Failure to Rescue Relationship in Acute Type A Aortic Dissections: An Analysis of The (..)

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52